Public Market Listing
Live quotes, historical charts, and market capitalization for Chipscreen Biosciences are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(4 total)
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | HDACSmall molecule | Non-Small Cell Lung CancerBreast CancerDiffuse Large B-Cell LymphomaColorectal CancerNon-Hodgkin Lymphoma HR+/HER2- Metastatic Breast Cancer, Peripheral T-Cell Lymphoma | |
Chiglitazar(Bilessglu) | Phase 3 | PPAR (pan-agonist)Small molecule | Type 2 Diabetes |
| Phase 1/2 | TYK2Small molecule | Psoriasis | |
| Phase 1 | PRMT5 (protein arginine methyltransferase 5), MTA-cooperativeSmall molecule | Non-Small Cell Lung Cancer |
Upcoming events
(3 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2027 (1)
2028 (1)
Regulatory and conference events
(1)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Recent
Financial reports
Quarterly & interim (1)
| Period | Revenue | R&D | Cash & equiv. | Net loss / qtr | Filing |
|---|---|---|---|---|---|
| 2026-Q3 | — | — | — | — | report ↗ |